Bay Area Ideas 6.06K Followers
Summary
I reiterate my Sell rating on Procter & Gamble. Sales are recovering, but shaky margins and an elevated valuation undermine risk/reward.
Fiscal Q1 organic sales grew 4%, driven primarily by volume and mix, while core gross margin ex-FX contracted 150 basis points.
FY2027 guidance implies 2% organic sales growth and 1.5% core EPS growth at the midpoints, making profitability the key recovery metric to scrutinize moving forward.
Procter & Gamble's 2.59% forward dividend yield and meaningful buybacks reward long-term holders, but a 24.10 forward P/E remains detached from slow-growth fundamentals.
BalkansCat/iStock Editorial via Getty Images
Introduction
Back in late May, I provided an update for The Procter & Gamble Company (PG) and decided to reiterate my sell rating on the stock.…